Article Information
History
- September 14, 2023.
Article Versions
- Version 1 (September 8, 2023 - 13:57).
- You are currently viewing Version 2 of this article (September 14, 2023 - 12:43).
- Version 3 (October 12, 2023 - 15:43).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Luz E. Cabrera1,*,
- Suvi T. Jokiranta2,3,
- Sanna Mäki1,
- Simo Miettinen1,4,
- Ravi Kant1,4,5,
- Lauri Kareinen1,4,
- Tarja Sironen1,4,
- Jukka-Pekka Pietilä6,7,
- Anu Kantele6,7,
- Eliisa Kekäläinen2,3,10,
- Hanna Lindgren11,
- Pirkko Mattila11,
- Anja Kipar4,8,9,
- Olli Vapalahti1,4,10 and
- Tomas Strandin1
- 1Viral Zoonosis Research Unit, Medicum, Department of Virology, University of Helsinki, Helsinki, Finland
- 2Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland
- 3Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
- 4Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland
- 5Department of Tropical Parasitology, Institute of Maritime and Tropical Medicine, Medical University of Gdansk, 81-519 Gdynia, Poland
- 6Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
- 7Meilahti Vaccine Research Center MeVac, Department of Infectious Diseases, Inflammation Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
- 8Laboratory for Animal Model Pathology, Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland
- 9Department of Infection Biology & Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L3 3RF, UK
- 10Division of Virology and Immunology, HUSLAB Clinical Microbiology, HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland
- 11Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland
- ↵* Corresponding author; email: luz.cabreralara{at}helsinki.fi
Posted September 14, 2023.
The assembly of neutrophil inflammasomes during COVID-19 is mediated by type I interferons
